Towards a brighter future for millions of patients Given the growing global prevalence of T2D and obesity, the implementation of sublingual formulations could have profound implications for public health
Research suggests it may increase endogenous GLP-1 secretion from intestinal L-cells, providing a mild GLP-1 boosting effect that complements rather than replaces exogenous GLP-1 therapy
7 In pancreatic -cells, GLP-1R activation by semaglutide enhances glucose catabolism and insulin secretion via the mTOR-dependent HIF-1 pathway, facilitating glycolysis and insulin release
Combining therapies requires careful professional oversight to ensure safety and synergy
Week 1: short-course trials measured sleep architecture and daytime alertness across 5-7 nights
You want someone monitoring how you feel, how youre eating, whether your dose is appropriate, and what happens after the scale starts moving